We are live on ! Find out more
U

UBS Portfolio holdings

AUM $136B
1-Year Est. Return 16.36%
This Fund
S&P 500
This Quarter Est. Return
+1.89%
1 Year Est. Return
+16.36%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$113B
AUM Growth
+$5.56B
Cap. Flow
+$4.14B
Cap. Flow %
3.68%
Top 10 Hldgs %
14.26%
Holding
11,559
New
1,144
Increased
4,238
Reduced
4,557
Closed
1,117

Sector Composition

Rank Sector Weight
1 Energy 8.95%
2 Financials 7.03%
3 Technology 6.55%
4 Healthcare 6.54%
5 Industrials 5.43%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DGI
4151
CALL
DELISTED
DigitalGlobe Inc.
DGI
$525K ﹤0.01%
18,100
+17,900
+8,950% +$654K
HLT icon
4152
Hilton Worldwide
HLT
$72.5B
$524K ﹤0.01%
7,852
+1,961
+33% +$130K
FNI
4153
DELISTED
First Trust Chindia ETF
FNI
$524K ﹤0.01%
18,074
+2,156
+14% +$62.3K
INSY
4154
DELISTED
Insys Therapeutics, Inc.
INSY
$524K ﹤0.01%
25,290
+22,665
+863% +$449K
PHYS icon
4155
Sprott Physical Gold
PHYS
$14.8B
$523K ﹤0.01%
49,001
-4,741
-9% -$51K
PSI icon
4156
Invesco Semiconductors ETF
PSI
$2.27B
$522K ﹤0.01%
75,444
-4,068
-5% -$26.3K
PBYI icon
4157
CALL
Puma Biotechnology
PBYI
$402M
$521K ﹤0.01%
5,000
+4,800
+2,400% +$564K
PBYI icon
4158
PUT
Puma Biotechnology
PBYI
$402M
$521K ﹤0.01%
+5,000
New +$588K
JOSB
4159
PUT
DELISTED
JOS A BANK CLOTHIERS INC
JOSB
$521K ﹤0.01%
8,100
-3,100
-28% -$181K
CORN icon
4160
CALL
Teucrium Corn Fund
CORN
$177M
$520K ﹤0.01%
15,000
+10,500
+233% +$336K
HOG icon
4161
CALL
Harley-Davidson
HOG
$2.59B
$520K ﹤0.01%
7,800
-21,600
-73% -$1.43M
DTH icon
4162
WisdomTree International High Dividend Fund
DTH
$655M
$519K ﹤0.01%
10,875
-9,991
-48% -$470K
TBRA
4163
DELISTED
Tobira Therapeutics, Inc. Common Stock
TBRA
$519K ﹤0.01%
4,604
+4,430
+2,546% +$311K
EQIX icon
4164
CALL
Equinix
EQIX
$103B
$518K ﹤0.01%
2,800
-16,600
-86% -$3.06M
GMED icon
4165
Globus Medical
GMED
$10.9B
$518K ﹤0.01%
19,481
-2,721
-12% -$64.7K
NRO
4166
Neuberger Real Estate Securities Income Fund Inc
NRO
$193M
$518K ﹤0.01%
115,067
-16,650
-13% -$72.5K
BDSI
4167
CALL
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$518K ﹤0.01%
61,400
+51,400
+514% +$415K
CEMP
4168
DELISTED
Cempra, Inc.
CEMP
$517K ﹤0.01%
44,800
+16,310
+57% +$203K
TFM
4169
CALL
DELISTED
THE FRESH MARKET, INC COM STK
TFM
$517K ﹤0.01%
15,400
-5,000
-25% -$176K
IRY
4170
DELISTED
SPDR S&P International Health Care Sector
IRY
$517K ﹤0.01%
11,039
-87
-0.8% -$4.01K
IPXL
4171
DELISTED
Impax Laboratories, Inc.
IPXL
$516K ﹤0.01%
19,563
+11,642
+147% +$291K
VKQ icon
4172
Invesco Municipal Trust
VKQ
$541M
$515K ﹤0.01%
42,539
+8,731
+26% +$105K
VXRT
4173
DELISTED
Vaxart
VXRT
$515K ﹤0.01%
7,657
+7,618
+19,533% +$471K
HA
4174
CALL
DELISTED
Hawaiian Holdings, Inc.
HA
$515K ﹤0.01%
36,900
-72,100
-66% -$842K
BEE
4175
DELISTED
STRATEGIC HOTELS & RESORTS, INC
BEE
$515K ﹤0.01%
50,519
+13,592
+37% +$132K

Similar funds

UBS's Q1 2014 Portfolio in Review

As of Q1 2014, UBS held 11,559 positions worth $113B, up 5.2% from $107B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

UBS deployed $4.14B of net new capital in Q1 2014, opening 1,144 new positions and adding to 4,238 existing holdings. Its largest new stake was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.

By sector, the portfolio is most concentrated in Energy at 9% of assets, up from 8.5% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Herc Holdings, an estimated $419M trimmed.

  • UBS's largest Q1 2014 buy was iShares MSCI USA Quality Factor ETF: 336,642 shares worth $19M.
  • UBS added most to State Street SPDR S&P 500 ETF Trust in Q1 2014, an estimated $1.61B increase.
  • UBS's biggest Q1 2014 reduction was Herc Holdings, cutting an estimated $419M.
  • UBS fully exited COLE REAL ESTATE INVESTMENTS, INC COM in Q1 2014, selling an estimated $233M.
  • UBS's ten largest holdings make up 14% of its $113B portfolio in Q1 2014.
  • UBS opened 1,144 new positions and closed 1,117 in Q1 2014.
  • UBS's portfolio value rose 5.2% quarter-over-quarter to $113B.

Based on UBS's 13F filing for Q1 2014, filed 15 May 2014.